Tenax Therapeutics EBITDA Margin Growth & History (TENX)

Tenax Therapeutics's ebitda margin was −29,762.21% for fiscal 2015.

View full Tenax Therapeutics company overview

Tenax Therapeutics annual ebitda margin history

Tenax Therapeutics annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
2015 · Apr 302015-04-30−29,762.21%−19404.79 pp
20142014-04-30−10,357.42%−9934.20 pp
20132013-04-30−423.22%+1779.62 pp
20122012-04-30−2,202.84%−12742.75 pp
20112011-04-3010,539.90%

Tenax Therapeutics ebitda margin trends

Between the periods ended 2011-04-30 and 2015-04-30, Tenax Therapeutics's ebitda margin decreased from 10,539.90% to −29,762.21%, a change of −40302.11 percentage points. The latest reported quarter, Q3 2014, shows −5,721.14%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tenax Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about TENX yet. Start the conversation.

Write the first post